Risks include injection site reactions, rare allergic responses, and hypokalaemia during treatment of severe anaemia
Research areas involving Retatrutide include: Metabolic pathway regulation Energy balance and nutrient signaling Hormone-related peptide signaling systems Cellular energy utilization Multi-receptor agonism and endocrine signaling coordination Metabolic adaptation in experimental models These findings remain part of an ongoing investigation, and reported observations should not be interpreted as proven clinical outcomes
Liraglutide, the active ingredient in Saxenda, was also used as a diabetes treatment (Victoza) for a few years before being approved for weight loss as Saxenda
Critics argue even low doses could increase infection susceptibility in vulnerable people
Its liquid delivery system ensures convenient consumption without the need for mixing, making it an ideal pre-workout companion
More in the final section of the article
